Startups & Entrepreneurship
$2.75B AI Chemist Deal: Lilly Pushes 14 Robot-Designed Drugs Into Trials
TL;DR * Eli Lilly and Insilico Medicine sign $2.75B AI drug development deal, with $115M upfront payment * Datavault AI Inc. reports record $33.8M Q4 revenue, 3,650% YoY growth, and first net profit of $661K 🤖 Lilly Bets $2.75B on AI-Designed Drugs in Global First $2.75B